Teva Pharmaceutical Industries Ltd., the biggest seller of Adderall in the US, has been experiencing “supply disruptions” of the popular ADHD drug at a time when demand is at all-time highs, a spokesperson for the company said.
The problems span some doses of branded and generic Adderall and are being caused by issues at one manufacturing facility. The disruptions could last into the fall, the company told Bloomberg News.
